Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/07/2003EP1308512A1 Novel proteins and dnas thereof
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308458A1 New polynucleotides and polypeptides of the CX26 gene
05/07/2003EP1307594A1 Association of sim2 with cancer
05/07/2003EP1307588A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
05/07/2003EP1307582A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
05/07/2003EP1307574A2 Targeting through integrins
05/07/2003EP1307573A2 Transduction of chondrocytes using adenoviral vectors
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same
05/07/2003EP1307545A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
05/07/2003EP1307235A2 Angiogenic and osteogenic proteins for use in enhancing bone density and formation
05/07/2003EP1307234A2 Methods for treatment of hyperproliferative diseases using human mda-7
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1232165B1 Phosphorus-containing dendrimers as transfection agents
05/07/2003EP1206576A4 Novel kinases and uses thereof
05/07/2003EP0836648B1 Recombinant mva virus, and the use thereof
05/07/2003CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CA2411186A1 Induction of tolerance to a therapeutic polypeptide
05/06/2003US6559286 Antibodies for use in the diagnosis and treatment of cancer
05/06/2003US6559285 Antibody for use in the treatment of cancer
05/06/2003US6559130 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
05/06/2003US6558952 Expansion of preferential pancreatic cells; generate nutrient broth, inoculate with pancreatic cells and gastrin receptor ligand, monitor propagation of pancreatic cells
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
05/06/2003US6558936 Human lipase proteins, nucleic acids encoding them, and uses of both of these
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558919 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infections
05/06/2003US6558905 Diagnosing osteoporosis in humans; obtain tissue sample, extract nucleotide sequences, digest, incubate with marker probe, detect presence of preferential allele, presence of allele indicate osteoporosis
05/06/2003US6558903 Kinases and uses thereof
05/06/2003US6558702 Mixture of polymer and bisphosphonate compound
05/06/2003US6558673 Polypeptide fragment derived from G protein of streptococcus which binds specifically to mammalian serum albumin; immuni-zation
05/06/2003US6558671 Tumor specific immunogens of modified naturally occurring epitope SEQ ID NO:19, 37 or 10
05/06/2003US6558663 Promoting tolerance and inhibiting natural killer cell mediated attack in human recipient to a swine graft
05/06/2003CA2126691C Gapped 2' modified oligonucleotides
05/06/2003CA2094144C Methods and applications for efficient genetic suppressor elements
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306436A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent
05/02/2003EP1305741A1 Online media exchange
05/02/2003EP1305636A2 Screening method
05/02/2003EP1305635A2 Methods to identify compounds that modulate rage
05/02/2003EP1305435A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
05/02/2003EP1305426A2 25324, 50287, 28899, 47007 and 42967, transferase family members, and uses therefor
05/02/2003EP1305414A2 Modified cea and uses thereof
05/02/2003EP1305410A2 Insulin producing cell-line obtained by electrofusion
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1189611A4 Cancer therapy
05/02/2003EP1036167B1 Nuclear targeting by means of streptococcal protein h
05/02/2003EP1007675A4 Porcine mhc class i genes and uses thereof
05/02/2003EP0879294B1 Transduced human hematopoietic stem cells
05/01/2003WO2003035883A2 Methods and compositions for inducing tumor-specific cytotoxicity
05/01/2003WO2003035879A2 Promoters to control cell differentiation
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035870A1 Drug for treating a carcinoma of the pancreas
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035855A1 Differentiation of whole bone marrow
05/01/2003WO2003035849A2 Methods for gene transfer using pseudotyped lentiviruses
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035845A2 Salvador tumor suppressor gene
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035685A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4
05/01/2003WO2003035105A2 A synthetic chimeric fusion protein with immuno-therapeutic uses
05/01/2003WO2003035083A1 Drug for treating a fibrotic disease through rna interfence
05/01/2003WO2003035082A1 Drug for inhibiting expression of a target gene
05/01/2003WO2003035048A2 Methods for the treatment of osteoarthritis and compositions thereof
05/01/2003WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003WO2003035010A2 Thymosin augmentation of genetic immunization
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003004685A3 Soluble steroidal peptides for nucleic acid delivery
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002100335A3 Methods for improving cell line activity in immunoisolation devices
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002098287A3 A high throughput biological heart rate monitor that is molecularly determined
05/01/2003WO2002092798A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein
05/01/2003WO2002083183A3 Stimulation of the immune system
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002078630A3 Tub 3'-variant
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002026250A3 Vaccines for proliferative ileitis
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084471 Methods and compositions for RNA interference
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083642 Devices and methods for the restoration of a spinal disc
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083482 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 870